Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sea trials of Marine MSAR fuel

27 Sep 2011 07:00

RNS Number : 9480O
Quadrise Fuels International PLC
27 September 2011
 



27 September 2011

 

Quadrise Fuels International Plc ("QFI", "Quadrise" or the "Company")

 

Sea trials of Marine MSAR® fuel - a key step towards commercialisation

 

Quadrise International Limited ("QIL"), is the emerging supplier of MSAR®, a low cost alternative to heavy fuel oil in the shipping, refining and power generation markets.

 

Quadrise is pleased to announce the closing of contracts to commence sea trials of Marine MSAR®, moving the Company a step closer to commercialisation.

 

QIL entered into contracts on 26 September 2011 with A.P.Møller-Mærsk ("Mærsk"), AB Orlen Lietuva ("Orlen Lietuva") and AkzoNobel Surface Chemistry AB ("AkzoNobel"). These agreements define the contributions and responsibilities for all facets of the production and evaluation programme.

 

The trial commences with the installation of an MSAR® manufacturing unit at the 200,000 barrel per day Orlen Lietuva refinery in Mazeikiai Lithuania, followed by the production of an initial volume of Marine MSAR® fuel. The fuel will then be transferred to the nominated vessel for consumption and evaluation.

 

The QIL team is now deployed at the refinery site to manage project installations, subsequent operation of the AkzoNobel MSAR® manufacturing plant, and fuel quality assurance throughout the supply chain.

 

The results of the evaluation programme are expected during the first half of 2012.

 

The forward plan, beyond the initial sea trial, remains subject to third party verification and approvals, and the conclusion of commercial agreements with candidate oil refineries. Quadrise then anticipates progressive commercial quantities of Marine MSAR® will be produced during 2012 to allow the wider evaluation of performance across a representative range of vessels.

 

Commenting on this development, Ian Williams, Executive Chairman of QFI, said:

 

"These sea trials represent a key milestone for the Company and, potentially, for the marine sector. QIL and its partners have worked tirelessly to get to this stage of Marine MSAR® evaluation. We look forward to confirming the opportunity that this represents for the Company and our partners in the marine fuels industry."

 

-ENDS-

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Ian Williams, Executive Chairman

Hemant Thanawala, Finance Director

Quadrise Fuels International Plc

 

+44 (0)20 7550 4930

 

Dr Azhic Basirov / Siobhan Sergeant

Nominated Adviser

Smith & Williamson Corporate Finance Limited

 

+44 (0)20 7131 4000

Dermot McKechnie / Petre Norton

Broker

Westhouse Securities Limited

 

+ 44 (0)20 7601 6100

Philip Dennis / Nick Lambert / Rollo Crichton-Stuart

Public & Investor Relations

Pelham Bell Pottinger

+44 (0)20 7861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFMITMBATBIB
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.